Talk:Ran Balicer

Edit request for article text improvements

Hello, I would like to kindly request your help with a editing of the Ran Balicer article. I have a lot of small changes so i believe it would be easier just to go for a full-text replacement of the current article on to better reflect Wikipedia's Manual of Style and improve clarity, neutrality, and structure. The updated verssion is more concise, better organized into thematic sections, and uses more neutral language. Below is a section-by-section breakdown of the proposed changes and rationale. (references should of course remain the same)

Proposed full text:

Ran Balicer (Hebrew: רן בליצר) is an Israeli physician, epidemiologist, and public health researcher. He serves as Chief Innovation Officer and Deputy Director General at Clalit Health Services, Israel’s largest healthcare provider, and is the founding director of the Clalit Research Institute. He also chairs the Israeli Medical Association's Society for Quality in Healthcare.

Balicer’s work focuses on the integration of data science and digital tools into healthcare systems. He has contributed to public health policy in Israel and has served in advisory roles to international organizations, including the World Health Organization.

Early life and education

Balicer was born and raised in Israel. At the age of 16, he began medical studies at the Sackler School of Medicine at Tel Aviv University. After completing his degree, he served in the Israel Defense Forces, eventually leading the Epidemiology Department of the IDF Medical Corps. He earned a Ph.D. in health systems management and a Master of Public Health from Ben-Gurion University of the Negev. He became a full professor of medicine at the age of 36.

Career

Roles at Clalit Health Services

Balicer serves as Chief Innovation Officer and Deputy Director General at Clalit Health Services, Israel’s largest health maintenance organization. He is also the founding director of the Clalit Research Institute, where he oversees initiatives related to healthcare delivery, population health, and digital transformation. At Clalit, his role involves the integration of electronic health records and data analytics into healthcare management and delivery.

Public Health and COVID-19 Response

Balicer has held advisory roles in Israel’s Ministry of Health and contributed to national health strategy. During the COVID-19 pandemic, he was appointed head of Israel’s National Expert Advisory Team, providing strategic guidance to senior policymakers and participating in high-level government forums. He also served on the national Epidemic Management Team.

Digital Health and Artificial Intelligence

Balicer’s research includes applications of digital tools and artificial intelligence in preventive and personalized medicine. He has worked on integrating artificial intelligence and digital technologies into public health initiatives and has published on related policy and ethical considerations. In addition to his work in Israel, he advised the French government on its "AI for Humanity" initiative and participated in healthcare reform discussions with German officials.

International Collaboration and Governance

In 2019, Balicer was appointed a commissioner for The Lancet and Financial Times health commissions. He is also involved with the Governing Health Futures 2030 project, which focuses on digital health and youth. In 2023, Balicer joined the board of the Healthcare Information and Management Systems Society (HIMSS), an international body focused on digital health systems. That same year, he was appointed to the United Nations Secretary-General’s AI Advisory Board, which is tasked with guiding global policy on artificial intelligence.

Recognition

Balicer has received recognition in Israeli media, including listings in TheMarker’s “40 Promising Young People” (2010) and “100 Most Influential People in Israel” (2017), as well as Globes’ “40 Leading Young Managers” (2012) and “People of the Year” (2021). In 2014, he was named chair of the WHO Collaborating Centre on Noncommunicable Diseases Research, Prevention and Control. In 2025, he was appointed honorary professor at Charité – Universitätsmedizin Berlin. He has authored more than 250 peer-reviewed scientific publications.

Personal life

Balicer lives in Israel with his spouse and three children.

Summary of changes and rationale

- Tone: Replaces promotional or vague wording (e.g. "significant role", "known for") with neutral, factual phrasing.

- Redundancy: Removes repeated facts and improves flow.

- Clarity: Sentences reworded for clarity and precision

- Consistency: Unifies style (e.g., date formatting, name spelling, institution references).

Please let me know if something is not clear or if you need anything else from my side.

Thank you and kind regards,

MrEksh (talk) 13:48, 13 July 2025 (UTC)

@ Chaotic Enby Your kind help on the matter would be highly appreciated2A06:C701:4A66:4C00:1088:AEDF:9BD9:8776 (talk) 15:06, 20 July 2025 (UTC)

 Not done no sources. Theroadislong (talk) 11:30, 27 July 2025 (UTC)

The links should remain the same

There are 16 approved sources on the original article that have been approved already- my request is dealing with the The wording alone - this is based on the strength of the sources MrEksh (talk) 12:11, 27 July 2025 (UTC)

@theroadisilong would you please review and answer MrEksh (talk) 13:12, 29 July 2025 (UTC)

No I am not interested in doing that for you, please request edits with the template {{edit COI}} and get other opinions. Theroadislong (talk) 13:21, 29 July 2025 (UTC)

Edit request for article text improvements

Hello, I would like to kindly request your help with editing the Ran Balicer article. I have a lot of small changes, so I believe it would be easier to go for a full-text replacement of the current article to better reflect Wikipedia's Manual of Style and improve clarity, neutrality, and structure. The updated version is more concise, better organized into thematic sections, and uses more neutral language. Below is a section-by-section breakdown of the proposed changes and rationale. (References should of course remain the same.)

Proposed full text

Ran Balicer (Hebrew: רן בליצר) is an Israeli physician, epidemiologist, and public health researcher. He serves as Chief Innovation Officer and Deputy Director General at Clalit Health Services, Israel’s largest healthcare provider, and is the founding director of the Clalit Research Institute. He also chairs the Israeli Medical Association's Society for Quality in Healthcare.

Balicer’s work focuses on the integration of data science and digital tools into healthcare systems. He has contributed to public health policy in Israel and has served in advisory roles to international organizations, including the World Health Organization.

Early life and education Balicer was born and raised in Israel. At the age of 16, he began medical studies at the Sackler School of Medicine at Tel Aviv University. After completing his degree, he served in the Israel Defense Forces, eventually leading the Epidemiology Department of the IDF Medical Corps. He earned a Ph.D. in health systems management and a Master of Public Health from Ben-Gurion University of the Negev. He became a full professor of medicine at the age of 36.

Career

Roles at Clalit Health Services Balicer serves as Chief Innovation Officer and Deputy Director General at Clalit Health Services, Israel’s largest health maintenance organization. He is also the founding director of the Clalit Research Institute, where he oversees initiatives related to healthcare delivery, population health, and digital transformation. At Clalit, his role involves the integration of electronic health records and data analytics into healthcare management and delivery.

Public Health and COVID-19 Response Balicer has held advisory roles in Israel’s Ministry of Health and contributed to national health strategy. During the COVID-19 pandemic, he was appointed head of Israel’s National Expert Advisory Team, providing strategic guidance to senior policymakers and participating in high-level government forums. He also served on the national Epidemic Management Team.

Digital Health and Artificial Intelligence Balicer’s research includes applications of digital tools and artificial intelligence in preventive and personalized medicine. He has worked on integrating artificial intelligence and digital technologies into public health initiatives and has published on related policy and ethical considerations. In addition to his work in Israel, he advised the French government on its "AI for Humanity" initiative and participated in healthcare reform discussions with German officials.

International Collaboration and Governance In 2019, Balicer was appointed a commissioner for The Lancet and Financial Times health commissions. He is also involved with the Governing Health Futures 2030 project, which focuses on digital health and youth. In 2023, Balicer joined the board of the Healthcare Information and Management Systems Society (HIMSS), an international body focused on digital health systems. That same year, he was appointed to the United Nations Secretary-General’s AI Advisory Board, which is tasked with guiding global policy on artificial intelligence.

Recognition Balicer has received recognition in Israeli media, including listings in TheMarker’s “40 Promising Young People” (2010) and “100 Most Influential People in Israel” (2017), as well as Globes’ “40 Leading Young Managers” (2012) and “People of the Year” (2021). In 2014, he was named chair of the WHO Collaborating Centre on Noncommunicable Diseases Research, Prevention and Control. In 2025, he was appointed honorary professor at Charité – Universitätsmedizin Berlin. He has authored more than 250 peer-reviewed scientific publications.

Personal life Balicer lives in Israel with his spouse and three children.

Summary of changes and rationale

• Tone: Replaces promotional or vague wording (e.g., "significant role", "known for") with neutral, factual phrasing.
• Redundancy: Removes repeated facts and improves flow.
• Clarity: Sentences reworded for clarity and precision.
• Consistency: Unifies style (e.g., date formatting, name spelling, institution references).

As for the references – I would like them to stay the same as in the article right now; they were all approved already.

Please let me know if something is not clear or if you need anything else from my side.

Thank you and kind regards,MrEksh (talk) 10:10, 31 July 2025 (UTC)